227 related articles for article (PubMed ID: 9586903)
1. Combination of consecutive low-dose cisplatin with bleomycin, vincristine, and mitomycin for recurrent cervical carcinoma.
Shimizu Y; Akiyama F; Umezawa S; Ishiya T; Utsugi K; Hasumi K
J Clin Oncol; 1998 May; 16(5):1869-78. PubMed ID: 9586903
[TBL] [Abstract][Full Text] [Related]
2. [Treatment of advanced or recurrent cervical cancer by a new BOMP regimen consisting of bleomycin, vincristine, mitomycin-C, and low-dose consecutive cisplatin].
Shimizu Y; Nakayama K; Seimiya Y; Yamakawa Y; Koi S; Yokosuka K; Teshima H; Chen JT; Fujimoto I; Yamauchi K
Nihon Sanka Fujinka Gakkai Zasshi; 1991 May; 43(5):549-56. PubMed ID: 1711555
[TBL] [Abstract][Full Text] [Related]
3. A randomized study of primary bleomycin, vincristine, mitomycin and cisplatin (BOMP) chemotherapy followed by radiotherapy versus radiotherapy alone in stage IIIB and IVA squamous cell carcinoma of the cervix.
Tabata T; Takeshima N; Nishida H; Hirai Y; Hasumi K
Anticancer Res; 2003; 23(3C):2885-90. PubMed ID: 12926129
[TBL] [Abstract][Full Text] [Related]
4. Chemotherapy of advanced or recurrent cervical carcinoma with a consecutive low-dose cisplatin combined with bleomycin, vincristine, and mitomycin-C (consecutive low-dose BOMP).
Shimizu Y
Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():359-77. PubMed ID: 10895181
[TBL] [Abstract][Full Text] [Related]
5. [BOMP (BLM, VCR, MMC, and CDDP) therapy for advanced cervical cancer].
Katayama H; Yamashita T; Sengoku K; Ishikawa M
Nihon Rinsho; 2004 Oct; 62 Suppl 10():187-91. PubMed ID: 15535231
[No Abstract] [Full Text] [Related]
6. Treatment of advanced or recurrent squamous cell carcinoma of the uterine cervix with mitomycin-C, bleomycin, and cisplatin chemotherapy.
Smith HO; Stringer CA; Kavanagh JJ; Gershenson DM; Edwards CL; Wharton JT
Gynecol Oncol; 1993 Jan; 48(1):11-5. PubMed ID: 7678571
[TBL] [Abstract][Full Text] [Related]
7. Final report of a phase II study of chemotherapy with bleomycin, epirubicin, and cisplatin for locally advanced and metastatic/recurrent undifferentiated carcinoma of the nasopharyngeal type.
Azli N; Fandi A; Bachouchi M; Rahal M; Lianes P; Wibault P; Boussen H; Eschwege F; Armand JP; Cvitkovic E
Cancer J Sci Am; 1995; 1(3):222-9. PubMed ID: 9166480
[TBL] [Abstract][Full Text] [Related]
8. Lomustine (chloroethylnitrosourea [CCNU]), ifosfamide, bleomycin, vincristine, and cisplatin (CIBO-P) is an effective regimen for patients with poor prognostic refractory or multiple disease recurrent aggressive non-Hodgkin lymphoma.
Musolino A; Perrone MA; Michiara M; Delnevo D; Franciosi V; Di Blasio B; Ceci G; Camisa R; Ardizzoni A; Cocconi G
Cancer; 2005 May; 103(10):2109-17. PubMed ID: 15803492
[TBL] [Abstract][Full Text] [Related]
9. Phase II study of neoadjuvant chemotherapy with mitomycin-c, vincristine and cisplatin (MVC) in patients with stages IB2-IIB cervical carcinoma.
Choi CH; Kim TJ; Lee JW; Kim BG; Lee JH; Bae DS
Gynecol Oncol; 2007 Jan; 104(1):64-9. PubMed ID: 16904170
[TBL] [Abstract][Full Text] [Related]
10. Phase II trial of chemotherapy with 5-fluorouracil, bleomycin, epirubicin, and cisplatin for patients with locally advanced, metastatic, or recurrent undifferentiated carcinoma of the nasopharyngeal type.
Taamma A; Fandi A; Azli N; Wibault P; Chouaki N; Hasbini A; Couteau C; Armand JP; Cvitkovic E
Cancer; 1999 Oct; 86(7):1101-8. PubMed ID: 10506692
[TBL] [Abstract][Full Text] [Related]
11. [A case of recurrent squamous cell carcinoma of cervix successfully treated with BOMP].
Matsui R; Kashihara K; Higashi T; Seo K; Taoka Y; Yoshida S; Nishitani H; Takegawa Y; Hukumura Y
Gan To Kagaku Ryoho; 1996 Dec; 23(14):1985-8. PubMed ID: 8978808
[TBL] [Abstract][Full Text] [Related]
12. Bleomycin, vincristine, and mitomycin C (BOM) as second-line treatment after failure of cis-platinum-based combination chemotherapy for recurrent cervical cancer.
Wheelock JB; Krebs HB; Goplerud DR
Gynecol Oncol; 1990 Apr; 37(1):21-3. PubMed ID: 1691126
[TBL] [Abstract][Full Text] [Related]
13. Combination chemotherapy for patients with advanced carcinoma of the cervix: trial of mitomycin-C, vincristine, bleomycin, and cisplatin.
Giannone L; Brenner DE; Jones HW; Greco FA; Burnett LS
Gynecol Oncol; 1987 Feb; 26(2):178-82. PubMed ID: 2433196
[TBL] [Abstract][Full Text] [Related]
14. [Intraarterial combination chemotherapy consisting of bleomycin, vincristine, mitomycin-C, and cisplatin (BOMP) for cervical cancer recurrence in the pelvis].
Shimizu Y; Fujimoto I; Hasumi K; Masubuchi K
Nihon Sanka Fujinka Gakkai Zasshi; 1991 Nov; 43(11):1587-90. PubMed ID: 1719107
[No Abstract] [Full Text] [Related]
15. [Chemotherapy of cancers of the uterine cervix with a combination of bleomycin, mitomycin, cisplatin and etoposide].
Chauvergne J; Héron JF; Mayer F; Charrot-Chinet P; Toulouse C
Bull Cancer; 1993 Jan; 80(1):70-9. PubMed ID: 7515729
[TBL] [Abstract][Full Text] [Related]
16. Treatment of recurrent head and neck cancer with cisplatin and 5-fluorouracil vs. the same plus bleomycin and methotrexate.
Amrein PC; Fabian RL
Laryngoscope; 1992 Aug; 102(8):901-6. PubMed ID: 1379664
[TBL] [Abstract][Full Text] [Related]
17. A phase II trial of mitomycin, vincristine, bleomycin, and cisplatin (MOBP) as neoadjuvant therapy in high-risk cervical carcinoma.
Weiner SA; Aristizabal S; Alberts DS; Surwit EA; Deatherage-Deuser K
Gynecol Oncol; 1988 May; 30(1):1-6. PubMed ID: 2452769
[TBL] [Abstract][Full Text] [Related]
18. Bleomycin-ifosfamide-cis-platinum (BIP) in pelvic recurrence of previously irradiated cervical carcinoma: a second look.
Ramm K; Vergote IB; Kaern J; Tropé CG
Gynecol Oncol; 1992 Aug; 46(2):203-7. PubMed ID: 1379961
[TBL] [Abstract][Full Text] [Related]
19. Chemotherapy of recurrent/advanced cervical cancer: results of the Yale University PBM-PFU protocol.
Chambers SK; Lamb L; Kohorn EI; Schwartz PE; Chambers JT
Gynecol Oncol; 1994 May; 53(2):161-9. PubMed ID: 7514557
[TBL] [Abstract][Full Text] [Related]
20. Cervix carcinoma: treatment with combination cisplatin and bleomycin.
Daghestani AN; Hakes TB; Lynch G; Lewis JL
Gynecol Oncol; 1983 Dec; 16(3):334-9. PubMed ID: 6197345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
